← Eichor
Study identifier: NCT03653338 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias

Condition: Sickle Cell Anemia · Beta-thalassemia Major · Diamond-blackfan Anemia  ·  Sponsor: Paul Szabolcs

PhasePhase 1/Phase 2
Planned participants5
Who can joinAll sexes, 5 Years to 40 Years
Healthy volunteersNo

About this study

The purpose of this study is to evaluate what effect, if any, mismatched unrelated volunteer donor and/or haploidentical related donor stem cell transplant may have on severe sickle cell disease and other transfusion dependent anemias. By using mismatched unrelated volunteer donor and/or haploidentical related donor stem cells, this study will increase the number of patients who can undergo a stem cell transplant for their specified disease. Additionally, using a T-cell depleted approach should reduce the incidence of graft-versus-host disease which would otherwise be increased in a mismatched transplant setting.

This description comes directly from the study's public registry record.

Talk to the study team

Paul Szabolcs, MD  ·  412-692-6225  ·  paul.szabolcs@chp.edu

Shawna McIntyre, RN  ·  412-692-5552  ·  mcintyresm@upmc.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Children's Hospital of Pittsburgh of UPMCPittsburgh, Pennsylvania, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03653338